Pediatric transplantation · 2026
Ultra-Low Weight < 5 Versus 5-9.9-kg Pediatric Liver Transplant Recipients: Characteristics and Intraoperative Vasopressor Comparisons.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Aronson Lori A, Li Kim My, Bondoc Alexander J, Hartman Stephen, Stetson Alyssa, Hartzell Cheryl, Noriega Nicolas, Ding Lili, Lee Jiwon
Аннотация
BACKGROUND: Survival in pediatric liver transplantation (PLT) has significantly improved in infants under 1 year, but < 10 kg and < 6 months continue to have poor outcomes with a paucity of information on ultra-low weight (ULW) infants (< 5 kg). We compared intraoperative vasopressor use in < 5 kg versus 5-< 9.9 kg PLT recipients.
METHODS: We conducted a single-center retrospective review of all PLT recipients < 10 kg at time of transplant from 2009 to 2022, excluding multi-organ transplantation. We collected data on demographics, diagnosis, intraoperative vasoactive infusions, blood loss and requirements, and abdominal closure timing. Outcomes data include total mechanical ventilation, intensive care and hospital length of stay days, 1-year patient and graft survival and thrombotic complications.
RESULTS: ULW < 5 kg and 5-9.9 kg patients showed average weight of 4.53 versus 7.30 kg (p-value < 0.0001) and average age of transplant 3.36 versus 7.90 months (p-value 0.0002). The most common etiology of liver disease for ULW versus 5-9.9 kg was neonatal acute liver failure (3 of 5) versus biliary atresia (41 of 63). No significant difference in anhepatic time, abdominal closure, blood products transfused/kg, estimated blood loss/kg was noted. Total days of mechanical ventilation, ICU and hospital LOS were similar between groups. ULW trends toward higher doses of vasopressors during PLT, most notably at end of case compared to 5-9.9 kg (p = 0.06). Overall, 1-year graft and patient survival were 91% and 94%, respectively. HAT and PVT did not appear to be associated with VIS by phase of surgery, but PVT occurred relatively more in the < 5 kg group (2 vs. 4) and HAT in the 5-9.9 kg group (0 vs. 3).
CONCLUSIONS: Results show etiology of liver failure differs and < 5 kg trends to an increased amount of vasopressor use, especially at end of case, suggesting more hemodynamic instability requiring support; however, this did not correlate with measured hospital metrics. Split graft PLT recipients have more blood loss and require more transfusions. PVT was observed more in the < 5 kg cohort. Etiology, not just size or early age, may contribute to the higher and sustained pressor requirements and possible PVT risk in ULW infants.
METHODS: We conducted a single-center retrospective review of all PLT recipients < 10 kg at time of transplant from 2009 to 2022, excluding multi-organ transplantation. We collected data on demographics, diagnosis, intraoperative vasoactive infusions, blood loss and requirements, and abdominal closure timing. Outcomes data include total mechanical ventilation, intensive care and hospital length of stay days, 1-year patient and graft survival and thrombotic complications.
RESULTS: ULW < 5 kg and 5-9.9 kg patients showed average weight of 4.53 versus 7.30 kg (p-value < 0.0001) and average age of transplant 3.36 versus 7.90 months (p-value 0.0002). The most common etiology of liver disease for ULW versus 5-9.9 kg was neonatal acute liver failure (3 of 5) versus biliary atresia (41 of 63). No significant difference in anhepatic time, abdominal closure, blood products transfused/kg, estimated blood loss/kg was noted. Total days of mechanical ventilation, ICU and hospital LOS were similar between groups. ULW trends toward higher doses of vasopressors during PLT, most notably at end of case compared to 5-9.9 kg (p = 0.06). Overall, 1-year graft and patient survival were 91% and 94%, respectively. HAT and PVT did not appear to be associated with VIS by phase of surgery, but PVT occurred relatively more in the < 5 kg group (2 vs. 4) and HAT in the 5-9.9 kg group (0 vs. 3).
CONCLUSIONS: Results show etiology of liver failure differs and < 5 kg trends to an increased amount of vasopressor use, especially at end of case, suggesting more hemodynamic instability requiring support; however, this did not correlate with measured hospital metrics. Split graft PLT recipients have more blood loss and require more transfusions. PVT was observed more in the < 5 kg cohort. Etiology, not just size or early age, may contribute to the higher and sustained pressor requirements and possible PVT risk in ULW infants.